# Decoy Therapeutics Inc.: Form 8-K, filed Sep 18, 2025

- Company: [Decoy Therapeutics Inc.](/companies/dcoy.md) (CIK 1615219)
- Form: 8-K
- Filed: 2025-09-18
- Accepted by EDGAR: Sep 18, 2025, 11:01 ET
- Period: 2025-09-17
- Accession: 0001615219-25-000135
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000135/flks-20250917.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000135/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.03: Change to security holders’ rights
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1615219/000161521925000135/flks-20250917.htm

Filed Sep 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001615219-25-000135. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.